QSAR models for the human H(+)/peptide symporter, hPEPT1: affinity prediction using alignment-independent descriptors
Simon Birksø Larsen1, Flemming Steen Jørgensen, Lars Olsen
1Biostructural Research, Department of Medicinal Chemistry, Faculty of Pharmaceutical Sciences, University of Copenhagen, 2 Universitetsparken, DK-2100 Copenhagen, Denmark.
Abstract:
A data set comprising the major known chemical classes of hPEPT1 ligands was compiled from the literature. For these compounds, alignment-independent descriptors (VolSurf, GRIND/Almond, and MOE) were computed. Using hierarchical partial least-squares projection to latent structures (H-PLS), a one-component model with r2 = 0.77 and q2 = 0.75 was obtained. The model satisfied a set of rigorous validation criteria and performed well in the prediction of an external test set. Mechanistic interpretation of the model reveals polarity properties to be the dominant factors in determining hPEPT1 affinity, with hydrophobic interactions contributing to a lesser extent. The model is superior to previously reported models due to its combination of quality and speed. Accordingly, it is suitable for ligand-based virtual screening, such as QSAR-based database mining.
More Related Videos
08:31Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions
Published on: December 1, 2020
09:32Immunopeptidomics: Isolation of Mouse and Human MHC Class I- and II-Associated Peptides for Mass Spectrometry Analysis
Published on: October 15, 2021
Related Concept Videos
Conserved Binding Sites
Binding sites are often located in large pockets, and if their location on a protein’s surface is unknown, it can be predicted using various approaches. The energetic method computationally analyses the...
Structure-Activity Relationships and Drug Design
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence its...
